ChromaDex Corporation (NASDAQ:CDXC) Q3 2023 Earnings Call Transcript

Matt Dhane: Okay, that’s helpful. Also did want to ask about the Nestle launch. You may have mentioned this, I missed it. When did they launch their first product? And then what is your expectations around additional product launch insights and what can you share around that?

Rob Fried : They have multiple brands at Nestle. They launched with one of their brands called Solgar, which is their very, very high end dietary supplement brand. They launched it two weeks ago. We don’t know how they’re doing yet. They seem very enthusiastic. I believe they also launched another high end brand pure encapsulations launched the product as well. That’s mostly a healthcare practitioner channel that also has some consumer distribution. And we think they have and they’ve launched that and we think they have plans to launch another very high end brand of their vital proteins.

Matt Dhane: Okay. That’s helpful. Thank you.

Operator: With that I’ll hand the call back to Brianna for closing remarks.

Brianna Gerber : Thank you, Regina. There will be a replay of this call beginning at 4:30 PM. Pacific time today. The replay number is 1-800-770-2030 and the conference ID is 4126168. Thank you everyone for joining us today and for your continued support at ChromaDex.

Operator: This will conclude today’s meeting. We thank you again all for joining. You may now disconnect.